Immune Therapeutics Inc. Management Advises All Shareholders to Vote Their Proxy Card Today

Ads

You May Also Like

ABLYNX ANNOUNCES 2016 FULL YEAR RESULTS

REGULATED INFORMATION Significant progress in key pre-clinical and clinical development programmes Conference call and ...

NSAV Subsidiary Signs Major Agreement With Eli Lilly and Company

CRESCO, Pa., Dec. 14, 2017 (GLOBE NEWSWIRE) --  Net Savings Link, Inc. (OTC:NSAV) -- ...